In:
Eurosurveillance, European Centre for Disease Control and Prevention (ECDC), Vol. 25, No. 42 ( 2020-10-22)
Abstract:
SARS-CoV-2 IgG screening of 1,000 antenatal serum samples in the Oxford area, United Kingdom, between 14 April and 15 June 2020, yielded a 5.3% seroprevalence, mirroring contemporaneous regional data. Among the 53 positive samples, 39 showed in vitro neutralisation activity, correlating with IgG titre (Pearson’s correlation p 〈 0.0001). While SARS-CoV-2 seroprevalence in pregnancy cohorts could potentially inform population surveillance, clinical correlates of infection and immunity in pregnancy, and antenatal epidemiology evolution over time need further study.
Type of Medium:
Online Resource
ISSN:
1560-7917
DOI:
10.2807/1560-7917.ES.2020.25.41.2001721
Language:
English
Publisher:
European Centre for Disease Control and Prevention (ECDC)
Publication Date:
2020
detail.hit.zdb_id:
2059112-3
Permalink